ALPHAGAN/ALPHAGAN P 0.1% is contraindicated in the following patients: Patients with hypersensitivity to brimonidine tartrate or any component of this medication; patients receiving monoamine oxidase (MAO) inhibitor therapy; neonates and infants (children under the age of 2 years). Refer to Use in Children under Precautions.